Your browser doesn't support javascript.
loading
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
Ferron, Gwénaël; De Rauglaudre, Gaëtan; Becourt, Stéphanie; Delanoy, Nicolas; Joly, Florence; Lortholary, Alain; You, Benoît; Bouchaert, Patrick; Malaurie, Emmanuelle; Gouy, Sebastien; Kaminsky, Marie-Christine; Meunier, Jérôme; Alexandre, Jérôme; Berton, Dominique; Dohollou, Nadine; Dubot, Coraline; Floquet, Anne; Favier, Laure; Venat-Bouvet, Laurence; Fabbro, Michel; Louvet, Christophe; Lotz, Jean-Pierre; Abadie-Lacourtoisie, Sophie; Desauw, Christophe; Del Piano, Francesco; Leheurteur, Marianne; Bonichon-Lamichhane, Nathalie; Rastkhah, Mansour; Follana, Philippe; Gantzer, Justine; Ray-Coquard, Isabelle; Pujade-Lauraine, Eric.
Affiliation
  • Ferron G; Institut Claudius Regaud, Département de Chirurgie Oncologique, IUCT Oncopole, Toulouse, France. Electronic address: gwenael.ferron@iuct-oncopole.fr.
  • De Rauglaudre G; Institut Sainte Catherine, Cancérologie Clinique, Avignon, France. Electronic address: g.derauglaudre@isc84.org.
  • Becourt S; Centre Oscar Lambret, Département de Gynécologie, Lille, France. Electronic address: s-becourt@o-lambret.fr.
  • Delanoy N; Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris (AP-HP), APHP. Centre, Department of Medical Oncology, Hôpital Européen Georges Pompidou, Paris, France. Electronic address: nicolas.delanoy@aphp.fr.
  • Joly F; Centre François Baclesse, Oncologie Médicale, Unicaen, Caen, France. Electronic address: f.joly@baclesse.unicancer.fr.
  • Lortholary A; Hôpital Privé du Confluent, Centre Catherine de Sienne, Nantes, France. Electronic address: alain.lortholary@groupeconfluent.fr.
  • You B; Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, Université Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon-Sud, EA3738 Centre pour l'Innovation en Cancérologie de LYon (CICLY), Lyon, France; GINECO-GINEGEPS, Paris, France. Electronic address:
  • Bouchaert P; Hôpital de la Milétrie - Centre Hospitalier Universitaire de Poitiers, Pôle Régional de Cancérologie, Service d'Oncologie, Poitiers, France. Electronic address: Patrick.BOUCHAERT@chu-poitiers.fr.
  • Malaurie E; Centre Hospitalier Intercommunal de Créteil, Oncologie Radiothérapie, Créteil, France. Electronic address: emmanuelle.malaurie@chicreteil.fr.
  • Gouy S; Gustave Roussy, Gynécologie Médicale, Villejuif, France. Electronic address: Sebastien.GOUY@gustaveroussy.fr.
  • Kaminsky MC; ICL Institut de Cancérologie de Lorraine, Oncologie Médicale, Vandoeuvre lès Nancy, France. Electronic address: mc.kaminsky@nancy.unicancer.fr.
  • Meunier J; Centre Hospitalier Régional d'Orléans, Service Oncologie Médicale, Orléans, France. Electronic address: jerome.meunier@chr-orleans.fr.
  • Alexandre J; Université de Paris Cité, Service d'Oncologie Médicale, AP-HP, Hôpital Cochin Port Royal, Paris, France. Electronic address: jerome.alexandre@aphp.fr.
  • Berton D; ICO Centre René Gauducheau, Boulevard Jacques Monod, Saint Herblain, France. Electronic address: dominique.berton@ico.unicancer.fr.
  • Dohollou N; Polyclinique Bordeaux Nord, Oncologie Radiothérapie, Bordeaux, France. Electronic address: n.dohollou@bordeauxnord.com.
  • Dubot C; Hôpital René Huguenin, Institut Curie, Oncologie Médicale, Saint Cloud, France. Electronic address: c.dubot-poitelon@baclesse.unicancer.fr.
  • Floquet A; Institut Bergonié, Oncologie, Bordeaux, France.
  • Favier L; Centre Georges François Leclerc, Oncologie Médicale, Dijon, France. Electronic address: lfavier@cgfl.fr.
  • Venat-Bouvet L; Centre Hospitalier Universitaire Dupuytren, Limoges, France. Electronic address: laurence.venat-bouvet@chu-limoges.fr.
  • Fabbro M; ICM Val d'Aurelle, Montpellier, France. Electronic address: Michel.Fabbro@icm.unicancer.fr.
  • Louvet C; Institut Mutualiste Montsouris, Paris, France. Electronic address: christophe.louvet@imm.fr.
  • Lotz JP; Hôpital Tenon, AP-HP, Sorbonne Université, Paris, France. Electronic address: jean-pierre.lotz@aphp.fr.
  • Abadie-Lacourtoisie S; ICO Paul Papin, Angers, France. Electronic address: Sophie.Abadie-Lacourtoisie@ico.unicancer.fr.
  • Desauw C; Centre Hospitalier Régional Universitaire de Lille - Hôpital Huriez, Lille, France. Electronic address: christophe.desauw@chru-lille.fr.
  • Del Piano F; Hopitaux du Leman, Thonon-Les-Bains, France. Electronic address: F-DELPIANO@ch-hopitauxduleman.fr.
  • Leheurteur M; Centre Henri Becquerel, Rouen, France. Electronic address: marianne.leheurteur@chb.unicancer.fr.
  • Bonichon-Lamichhane N; Clinique Tivoli, Bordeaux, France. Electronic address: n.bonichon-lamichhane@tivoli-oncologie.fr.
  • Rastkhah M; Centre Hospitalier Alpes Leman, Contamine-sur-Arve, France. Electronic address: mrastkhah@ch-alpes-leman.fr.
  • Follana P; Centre Antoine Lacassagne, Nice, France. Electronic address: philippe.follana@nice.unicancer.fr.
  • Gantzer J; ICANS, Institut de Cancérologie Strasbourg-Europe, Strasbourg, France. Electronic address: j.gantzer@icans.eu.
  • Ray-Coquard I; Centre Léon Bérard and Université Claude Bernard, Lyon, France. Electronic address: isabelle.ray-coquard@lyon.unicancer.fr.
  • Pujade-Lauraine E; ARCAGY-GINECO, Paris, France. Electronic address: epujade@arcagy.org.
Gynecol Oncol ; 170: 186-194, 2023 03.
Article in En | MEDLINE | ID: mdl-36706645

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Type: Article